Comprehensive Inpatient Treatment of Refractory Chronic Daily Headache
Authors:
- 25 March 2009
- journal article
- clinical trial
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 49 (4) , 555-562
Abstract
Objective.— (1) To assess outcome at discharge for a consecutive series of admissions to a comprehensive, multidisciplinary inpatient headache unit; (2) To identify outcome predictors. Background.— An evidence‐based assessment (2004) concluded that many refractory headache patients appear to benefit from inpatient treatment, underscoring the need for more research, including outcome predictors. Methods.— The authors completed a retrospective chart review of 283 consecutive admissions over 6 months. The inpatient program (mean length of stay = 13.0 days) included intravenous and oral medication protocols, drug withdrawal when indicated, cognitive‐behavior therapy, and other services when needed, including anesthesiological intervention. Patient‐reported pain levels and consensus of medical staff determined outcome status. Results.— The 267 completers (94%) included 212 women and 55 men (mean age = 40.3 years, range = 13‐74) from 43 states and Canada. The modal diagnosis was intractable, chronic daily headache (85%), predominantly migraine. Most (59%) had medication overuse headache (MOH), involving opioids (48%), triptans (16%), or butalbital‐containing analgesics (10%). Psychiatric diagnoses included stress‐related headache (82%), mood disorders (70%), anxiety disorders (49%), and personality disorders (PD, 26%). More patients with a PD (62%) had opioid‐related MOH than those with no PD (38%), P < .005. Of the completers, 78% had moderate to significant pain reduction, with comparable improvement in mood, function, and behavior. Clinical factors predicting moderate‐significant headache improvement were limited to MOH (84% vs 69%, P < .007) and presence of a PD (68% vs 81%, P < .03). Conclusions.— Most patients (78%) improved following aggressive, comprehensive inpatient treatment. Maintenance of improvement is likely to depend on multiple post‐discharge factors, including continuity of care, compliance, and home or work environment.Keywords
This publication has 32 references indexed in Scilit:
- Borderline Personality Disorder and MigraineHeadache: The Journal of Head and Face Pain, 2007
- Staging Headache Cases: Reconciling the Complexity of a Case With the Required Intensity of TreatmentHeadache: The Journal of Head and Face Pain, 2006
- Neural Correlates of Antinociception in Borderline Personality DisorderArchives of General Psychiatry, 2006
- Sustained Opioid Therapy Should Rarely Be Administered to Headache Patients: Clinical Observations, Literature Review, and Proposed GuidelinesHeadache Currents, 2006
- Opioids in the Treatment of Headache: Perspective from the BenchHeadache Currents, 2006
- Medication Overuse Headache (MOH) is a Biobehavioural DisorderCephalalgia, 2005
- Aversive tension in patients with borderline personality disorder: a computer‐based controlled field studyActa Psychiatrica Scandinavica, 2005
- Antinociceptive and nociceptive actions of opioidsJournal of Neurobiology, 2004
- Comprehensive/Tertiary Care for Headache: A 6‐Month Outcome StudyHeadache: The Journal of Head and Face Pain, 1999
- Prevalence of DSM-III personality disorders in the communitySocial Psychiatry and Psychiatric Epidemiology, 1989